Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

bictegravir-emtricitabine-tenofovir alafenamide

bictegravir-emtricitabine-tenofovir alafenamide
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Biktarvy TABLET, ORAL 50 mg-200 mg-25 mg      
Comments:

Biktarvy is formulary, not routinely stocked. Home supply should be used if available.

 

If/When bictegravir is available as an individual agent, Biktarvy will be substituted to individual components.

Reviewed: 28 Aug 2018 (Biktarvy)

Last updated: May. 18, 2022






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved